Adverse events152

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 152

Type	Event	Organ system	Group	Affected	At risk
other	Flushing	Vascular disorders	Nebivolo 5 mg MONOTHERAPY PERIOD	0	143
other	Flushing	Vascular disorders	Amlodipine 5 mg MONOTHERAPY PERIOD	0	158
other	Flushing	Vascular disorders	Nebivolo 5mg/Amlodipine 5 mg COMBINATION THERAPY PERIOD	1	279
other	Flushing	Vascular disorders	Nebivolo 5mg/Amlodipine 10mg COMBINATION THERAPY PERIOD	0	94
other	Feeling Hot	General disorders	Nebivolo 5 mg MONOTHERAPY PERIOD	0	143
other	Feeling Hot	General disorders	Amlodipine 5 mg MONOTHERAPY PERIOD	0	158
other	Feeling Hot	General disorders	Nebivolo 5mg/Amlodipine 5 mg COMBINATION THERAPY PERIOD	1	279
other	Feeling Hot	General disorders	Nebivolo 5mg/Amlodipine 10mg COMBINATION THERAPY PERIOD	1	94
other	Endometrial hyperplasia	Reproductive system and breast disorders	Nebivolo 5 mg MONOTHERAPY PERIOD	1	143
other	Endometrial hyperplasia	Reproductive system and breast disorders	Amlodipine 5 mg MONOTHERAPY PERIOD	0	158
other	Endometrial hyperplasia	Reproductive system and breast disorders	Nebivolo 5mg/Amlodipine 5 mg COMBINATION THERAPY PERIOD	0	279
other	Endometrial hyperplasia	Reproductive system and breast disorders	Nebivolo 5mg/Amlodipine 10mg COMBINATION THERAPY PERIOD	0	94
other	Ovarian cyst	Reproductive system and breast disorders	Nebivolo 5 mg MONOTHERAPY PERIOD	1	143
other	Ovarian cyst	Reproductive system and breast disorders	Amlodipine 5 mg MONOTHERAPY PERIOD	0	158
other	Ovarian cyst	Reproductive system and breast disorders	Nebivolo 5mg/Amlodipine 5 mg COMBINATION THERAPY PERIOD	0	279
other	Ovarian cyst	Reproductive system and breast disorders	Nebivolo 5mg/Amlodipine 10mg COMBINATION THERAPY PERIOD	0	94
other	Lung consolidation	Respiratory, thoracic and mediastinal disorders	Nebivolo 5 mg MONOTHERAPY PERIOD	0	143
other	Lung consolidation	Respiratory, thoracic and mediastinal disorders	Amlodipine 5 mg MONOTHERAPY PERIOD	1	158
other	Lung consolidation	Respiratory, thoracic and mediastinal disorders	Nebivolo 5mg/Amlodipine 5 mg COMBINATION THERAPY PERIOD	0	279
other	Lung consolidation	Respiratory, thoracic and mediastinal disorders	Nebivolo 5mg/Amlodipine 10mg COMBINATION THERAPY PERIOD	0	94

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05513937/events

API reference For AI assistants

Adverse events152

Sources 3

Read this list from software.